慢性肾脏病磁共振成像生物标志物:PARENCHIMA立场文件
该立场文件由欧洲科学与技术合作行动PARENCHIMA发布,旨在消除肾脏MRI生物标志物广泛评估、商业开发和临床应用的障碍。文中提出MRI需解决的关键临床问题,并给出加速研究和技术转化的实用建议。
要点
- 功能性肾脏MRI可定量评估血流、灌注、氧合及微结构(包括炎症和纤维化)。
- MRI生物标志物在慢性肾脏病等多种肾病中有改善管理的潜力。
- PARENCHIMA提出从技术验证到临床验证、成本效益和监管资质的转化路径建议。
核心结论
- PARENCHIMA立场文件提出肾脏MRI生物标志物需解决关键临床问题以推动临床广泛应用。
研究设计与样本
- PARENCHIMA是2017年初启动的多学科泛欧网络,本文件为其立场文件。
主要发现
- 功能性肾脏MRI技术可生成对肾血流、组织灌注、氧合和微结构(含炎症和纤维化)敏感的定量生物标志物。
临床怎么用
- 建议先在研究环境中评估肾脏MRI生物标志物,再逐步推动临床实践应用。
局限性
- 从技术验证到临床验证、成本效益证明和监管资质仍面临多项挑战。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Functional renal magnetic resonance imaging (MRI) has seen a number of recent advances, and techniques are now available that can generate quantitative imaging biomarkers with the potential to improve the management of kidney disease. Such biomarkers are sensitive to changes in renal blood flow, tissue perfusion, oxygenation and microstructure (including inflammation and fibrosis), processes that are important in a range of renal diseases including chronic kidney disease. However, several challenges remain to move these techniques towards clinical adoption, from technical validation through biological and clinical validation, to demonstration of cost-effectiveness and regulatory qualification. To address these challenges, the European Cooperation in Science and Technology Action PARENCHIMA was initiated in early 2017. PARENCHIMA is a multidisciplinary pan-European network with an overarching aim of eliminating the main barriers to the broader evaluation, commercial exploitation and clinical use of renal MRI biomarkers. This position paper lays out PARENCHIMA's vision on key clinical questions that MRI must address to become more widely used in patients with kidney disease, first within research settings and ultimately in clinical practice. We then present a series of practical recommendations to accelerate the study and translation of these techniques.
引用
- Selby NM, Blankestijn PJ, Boor P, et al. Magnetic resonance imaging biomarkers for chronic kidney disease: a position paper from the European Cooperation in Science and Technology Action PARENCHIMA. Nephrol Dial Transplant. 2018. PMID: 30137584. doi:10.1093/ndt/gfy152
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。